The Effects of Anxiety and Depression on Outcomes in Hematologic Malignancies: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

The Effects of Anxiety and Depression on Outcomes in Hematologic Malignancies: A Systematic Review and Meta-Analysis

  • By

  • Dorsa Salabat

  • Samaneh Toutounchian

  • Danyal Salabat

  • Armin Babaei

  • Mahda Malekshahi

  • Maryam Barkhordar

  • Zahra Salehi

  • December 22, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Psycho-Oncology
    • Cancer Epidemiology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Psychiatry
    • Behavioral Science

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Psychosocial Oncology
    • Clinical Research

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology
    • Behavioral Medicine
    • Translational Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hematology-Oncology
    • Psychiatry
    • Psycho-Oncology

Original Source(s)

The Effects of Anxiety and Depression on Outcomes in Hematologic Malignancies: A Systematic Review and Meta-Analysis

  • by Dorsa Salabat, Samaneh Toutounchian, Danyal Salabat, Armin Babaei, Mahda Malekshahi, Maryam Barkhordar, Zahra Salehi

  • December 22, 2025

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Synthetic short RNA in cancer